LARYNX SQUAMOUS CELL CARCINOMA
Clinical trials for LARYNX SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LARYNX SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LARYNX SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has gotten worse after first-line therapy. About 40 adults with certain types of head and neck cancer will receive the drug combi…
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New weekly drug combo offers hope for head and neck cancer patients unable to take standard chemo
Disease control Recruiting nowThis study tests a weekly combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab) in 32 people with metastatic head and neck cancer who cannot take the standard drug 5-fluorouracil. The goal is to see if this regimen shrinks tumors better than …
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Can immune markers predict success of alternative chemoradiotherapy in head and neck cancer?
Knowledge-focused Recruiting nowThis study looks at immune markers in tumor tissue, saliva, stool, and blood from 250 patients with head and neck cancers who cannot receive the standard chemotherapy drug cisplatin. Instead, they will receive chemoradiotherapy with docetaxel. The goal is to find out which immune…
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC
-
New alert system aims to cut cancer treatment delays
Knowledge-focused Recruiting nowThis study tests a new automated system to help head and neck cancer patients get their follow-up radiation therapy sooner after surgery. Delays can hurt outcomes, so the system uses alerts and risk predictions to speed up appointments. About 85 adults with oral or larynx cancer …
Matched conditions: LARYNX SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC